September 8, 2025
Dentsply Sirona has decided to retain its Wellspect Healthcare business as part of its portfolio following a comprehensive review of strategic alternatives, concluding that continued ownership offers greater long-term financial and strategic value to shareholders.
The review process, first announced in February 2025, examined a range of potential options for Wellspect, including a possible sale. As part of the evaluation, the company engaged with multiple external parties to assess interest in the business. After extensive analysis and deliberation, Dentsply Sirona determined that maintaining Wellspect as a subsidiary would generate superior value compared to other alternatives.
“After completing a thorough review of strategic options, we are confident that retaining Wellspect will deliver greater financial and strategic benefits to our stockholders,” said Dan Scavilla, President and Chief Executive Officer of Dentsply Sirona. “Wellspect is a category leader in the global continence care market, supported by a strong product pipeline, solid cash flow generation, and significant untapped market potential.”
Scavilla highlighted that recent investments in Wellspect are already producing positive results and that the business is expected to remain an important contributor to the company’s long-term growth strategy. He also noted that, since assuming the CEO role in August, he has engaged with a broad range of stakeholders to better understand expectations around performance and customer experience.
“While our foundation is solid, there is a clear opportunity to further improve how we serve customers and to move faster as an organization,” Scavilla added. “We plan to share more details on our strategic priorities and growth plans in the coming months.”
Wellspect is a long-established provider of bladder and bowel care solutions, with more than 40 years of experience in the continence care sector. Its portfolio includes well-known brands such as LoFric® and Navina™. The business has delivered consistent organic sales growth in recent years, including mid-single-digit growth in 2024, and operates within an estimated $2 billion global continence care market.
Dentsply Sirona, headquartered in Charlotte, North Carolina, is the world’s largest diversified manufacturer of professional dental products and technologies. The company is listed on Nasdaq under the ticker symbol XRAY.